Trials / Completed
CompletedNCT02041650
Paradigm Shift in the Treatment of Patients With ACS
Plaque Erosion: A New in Vivo Diagnosis and Paradigm Shift in the Treatment of Patients With Acute Coronary Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Yu Bo · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This protocol describes a pilot study intended to test the hypothesis that patients with acute coronary syndrome (ACS) caused by plaque erosion can be stabilized by effective antithrombotic treatment without stent implantation, thereby avoiding both early and late complications related to percutaneous coronary intervention (PCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ticagrelor |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-04-01
- Completion
- 2017-04-01
- First posted
- 2014-01-22
- Last updated
- 2018-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02041650. Inclusion in this directory is not an endorsement.